Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pegylated synthetic human C-peptide exhibits similar bioactivity to natural C-peptides (non-polyethylene glycolated) and demonstrates an extended plasma half-life, making it suitable for research in diabetic peripheral neuropathy [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Pegylated synthetic human C-peptide exhibits similar bioactivity to natural C-peptides (non-polyethylene glycolated) and demonstrates an extended plasma half-life, making it suitable for research in diabetic peripheral neuropathy [1]. |
In vivo | Pegylated synthetic human C-peptide (CBX129801) administered subcutaneously (s.c.) at doses of 0.4, 1.33, or 4.0 mg/kg/week for 39 weeks can induce cytoplasmic infiltration of foamy macrophages at the injection site tissues and draining axillary lymph nodes without causing systemic foamy macrophage vacuolization [1]. |
Cas No. | 1350661-05-0 |
Storage | keep away from moisture | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.